HSBC Holdings
STJ

HSBC Holdings’s St Jude Medical STJ Stock Holding History

HSBC Holdings’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-20,000
Closed -$1.1M – 2237
2016
Q1 		$1.1M Buy
+20,000
New +$1.09M ﹤0.01% 1310
2015
Q3 		– Sell
-251,111
Closed -$18.3M – 2276
2015
Q2 		$18.3M Buy
+251,111
New +$18.1M 0.04% 441
2013
Q4 		– Sell
-100
Closed -$5K – 1756
2013
Q3 		$5K Buy
+100
New +$5.15K ﹤0.01% 1641

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

HSBC Holdings's STJ Position: Q1 2017 in Review

HSBC Holdings sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,002,936 shares — an estimated $161M sold.

HSBC Holdings first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $161M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • HSBC Holdings reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • HSBC Holdings sold 2,002,936 St Jude Medical shares in Q1 2017, an estimated $161M.
  • HSBC Holdings first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • HSBC Holdings's St Jude Medical position peaked at $161M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.